Research findings show that vitamin B3 interacts with the specific receptor hydroxycarboxylic acid receptor 2 (HCAR2), leading to a decrease in amyloid plaque load and neuritic dystrophy in a mouse model of Alzheimer’s disease (5x FAD mice) (118). This evidence concerns the gene HCAR2 and amyloidosis.